The following IPOs are expected to price this week:
CHC Group (HELI), the world's largest commercial helicopter operator for the offshore oil and gas industry, plans to raise $500 million by offering 29.4 million shares at a price range of $16.00 to $18.00. At the midpoint of the proposed range, CHC Group would command a market value of $1.3 billion. CHC Group, which was founded in 1987, booked $1.7 billion in sales over the last 12 months. The Richmond, Canada-based company plans to list on the NYSE under the symbol HELI. J.P. Morgan, Barclays and UBS Investment Bank are the joint bookrunners on the deal.
Cypress Energy Partners LP (CELP), which provides environmental and inspection services to oil and natural gas companies, plans to raise $75 million by offering 3.8 million shares at a price range of $19.00 to $21.00. At the midpoint of the proposed range, Cypress Energy Partners LP would command a market value of $237 million. Cypress Energy Partners LP, which was founded in 2013, booked $380 million in sales over the last 12 months. The Tulsa, OK-based company plans to list on the NYSE under the symbol CELP. Raymond James, Baird, Stifel and BMO Capital Markets are the joint bookrunners on the deal.
EP Energy (EPE), an Apollo-backed oil and gas E&P focused on premier basins in TX, UT and LA, plans to raise $1.0 billion by offering 40.0 million shares at a price range of $23.00 to $27.00. At the midpoint of the proposed range, EP Energy would command a market value of $6.2 billion. EP Energy, which was founded in 1928, booked $1.6 billion in sales over the last 12 months. The Houston, TX-based company plans to list on the NYSE under the symbol EPE. Credit Suisse, J.P. Morgan, Citi and Goldman Sachs are the joint bookrunners on the deal.
RSP Permian (RSPP), an oil and natural gas E&P operating in the West Texas Permian Basin, plans to raise $400 million by offering 20.0 million shares at a price range of $19.00 to $21.00. At the midpoint of the proposed range, RSP Permian would command a market value of $1.5 billion. RSP Permian, which was founded in 2010, booked $113 million in sales over the last 12 months. The Dallas, TX-based company plans to list on the NYSE under the symbol RSPP. Barclays, J.P. Morgan, Tudor, Pickering, Holt & Co. and Raymond James are the joint bookrunners on the deal.
Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.
Last week, there was one IPO pricing. GlycoMimetics (GLYC), a clinical-stage biotech developing treatments for sickle cell episodes and AML ended up 13% from its IPO price.
